Sign Up Today and Learn More About Isomorphic Labs Stock
Invest in or calculate the value of your shares in Isomorphic Labs or other pre-IPO companies through EquityZen's platform.

Isomorphic Labs Stock
Isomorphic Labs provides AI-driven solutions for drug discovery and development.
About Isomorphic Labs Stock
Founded
2021
Industries
Software, Data and Analytics, Science and Engineering
Isomorphic Labs Press Mentions
Stay in the know about the latest news on Isomorphic Labs
Biotech's top money raisers of 2025
fiercebiotech • Mar 05, 2026
冰山融化时:传统药企的AI诺亚方舟何在?
phirda • Feb 25, 2026
DeepMind’s Demis Hassabis Warns AGI Remains Years Away Despite A.I. Breakthroughs
observer • Feb 19, 2026
Google AI CEO Demis Hassabis just tells everyone why Gemini and ChatGPT winning International Maths Olympiad is not big, as they can still ...
timesofindia • Feb 18, 2026
Isomorphic Labs, a Google DeepMind spinoff, unveils IsoDDE, a drug design system it says surpasses AlphaFold 3 in predicting biomolecular structures (Isomorphic Labs)
techmeme • Feb 11, 2026
Isomorphic Labs Management
Leadership team at Isomorphic Labs
Founder and CEO
Demis Hassabis
Chief Technology Officer
Sergei Yakneen

Join now and verify your accreditation status to gain access to:
- Isomorphic Labs Current Valuation
- Isomorphic Labs Stock Price
- Isomorphic Labs Management
- Available deals in Isomorphic Labs and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Isomorphic Labs Cap Table and Funding History by Share Class and Liquidity Preferences
- Isomorphic Labs Revenue and Financials
- Isomorphic Labs Highlights
- Isomorphic Labs Business Model
- Isomorphic Labs Risk Factors
- Isomorphic Labs Research Report from SACRA Research
Trading Isomorphic Labs Stock
How to invest in Isomorphic Labs stock?
Accredited investors can buy pre-IPO stock in companies like Isomorphic Labs through EquityZen funds. These investments are made available by existing Isomorphic Labs shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Isomorphic Labs stock?
Shareholders can sell their Isomorphic Labs stock through EquityZen's private company marketplace. EquityZen's network includes over 430K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."